CORFO released the results of Line 2 of its Applied Research and Development InnovaChile Program, the objective of which is to address economic challenges facing the country through applied technological research.
Among the awarded projects are two initiatives of the Center for the Development of Nanoscience and Nanotechnology (CEDENNA), one in the area of environment led by the researchers María Angélica Rubio and Nicolás Arancibia and the other in the field of nanobiomedicine under the direction of the academics Hugo Cárdenas and Pedro Orihuela.
For the Director of CEDENNA, Dora Altbir, this funding is the result of the intense work that the center has been doing with the private sector, building links to companies with based on new knowledge to benefit the country with the work of its scientists. “We are carrying out purposeful research”, stated the academic from the Universidad de Santiago.
The Program for Applied Research and Development Projects is a continuation of Line 1 of CORFO, “Applied Research and Development Profile”, which ended last August.
The awarded projects
The project “Application of Nanotechnology to Remove Trace Elements from Diverse Aqueous Matrices” is directed by María Angélica Rubio and Nicolás Arancibia and is supported by CODELCO.
The main objective is to design an easy-to-use low cost filter made of materials with an excellent capacity to absorb trace elements to be used in regions of Chile where high levels of trace elements in water and soil from mining operations represent a risk to human health.
Among the expected results is a system for removing trace elements of arsenic, bismuth and antimony arising from mining operations and assess the possibility that these elements can be used to recover metals of economic interest from the mining operation wastes.
The initiative “Development of a polymeric-based non-hormonal vaginal ring to inhibit ovulation” directed by Hugo Cárdenas and Pedro Orihuela involves four institutions: Minera Li3 Energy, the Sociedad de Inversiones Singularidad SPA, the Chilean Institute for Reproductive Medicine and the Universidad de Santiago de Chile.
Among the objectives of this project is to develop and test a prototype of a meloxicam vaginal ring as a non-hormonal contraceptive for women.
This research seeks to develop the first contraceptive method designed to inhibit ovulation without using hormones.
In both projects young researchers will play a leading role. In several cases it is the young researchers who bridge science and innovation, as well as among disciplines.